View in EDS PDF Full Text

Infliximab induction and maintenance therapy for moderate-to-severe psoriasis: a phase III, multicentre, double-blind trial.

Saved in:
Bibliographic Details
Title: Infliximab induction and maintenance therapy for moderate-to-severe psoriasis: a phase III, multicentre, double-blind trial.
Authors: Reich K (AUTHOR), Nestle FO (AUTHOR), Papp K (AUTHOR), Ortonne J (AUTHOR), Evans R (AUTHOR), Guzzo C (AUTHOR), Li S (AUTHOR), Dooley LT (AUTHOR), Griffiths CEM (AUTHOR), EXPRESS Study Investigators (CORPORATE AUTHOR)
Source: Lancet. 10/15/2005, Vol. 366 Issue 9494, p1367-1374. 8p.
Database: Psychology and Behavioral Sciences Collection
FullText Links:
  – Type: pdflink
Text:
  Availability: 0
Header DbId: pbh
DbLabel: Psychology and Behavioral Sciences Collection
An: 106203707
AccessLevel: 6
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Infliximab induction and maintenance therapy for moderate-to-severe psoriasis: a phase III, multicentre, double-blind trial.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AR" term="%22Reich+K%22">Reich K</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Nestle+FO%22">Nestle FO</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Papp+K%22">Papp K</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Ortonne+J%22">Ortonne J</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Evans+R%22">Evans R</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Guzzo+C%22">Guzzo C</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Li+S%22">Li S</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Dooley+LT%22">Dooley LT</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Griffiths+CEM%22">Griffiths CEM</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22EXPRESS+Study+Investigators%22">EXPRESS Study Investigators</searchLink> (CORPORATE AUTHOR)
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22Lancet%22">Lancet</searchLink>. 10/15/2005, Vol. 366 Issue 9494, p1367-1374. 8p.
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=pbh&AN=106203707
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1016/s0140-6736(05)67566-6
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        PageCount: 8
        StartPage: 1367
    Titles:
      – TitleFull: Infliximab induction and maintenance therapy for moderate-to-severe psoriasis: a phase III, multicentre, double-blind trial.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Reich K
      – PersonEntity:
          Name:
            NameFull: Nestle FO
      – PersonEntity:
          Name:
            NameFull: Papp K
      – PersonEntity:
          Name:
            NameFull: Ortonne J
      – PersonEntity:
          Name:
            NameFull: Evans R
      – PersonEntity:
          Name:
            NameFull: Guzzo C
      – PersonEntity:
          Name:
            NameFull: Li S
      – PersonEntity:
          Name:
            NameFull: Dooley LT
      – PersonEntity:
          Name:
            NameFull: Griffiths CEM
      – PersonEntity:
          Name:
            NameFull: EXPRESS Study Investigators
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 15
              M: 10
              Text: 10/15/2005
              Type: published
              Y: 2005
          Identifiers:
            – Type: issn-print
              Value: 01406736
          Numbering:
            – Type: volume
              Value: 366
            – Type: issue
              Value: 9494
          Titles:
            – TitleFull: Lancet
              Type: main
ResultId 1